Metallothionein expression in canine cutaneous apocrine gland tumors

Anticancer Research

Volumn 32, Issue 3, 2012, Pages 747-752

  Martano, Manuela ^a   Carella, Francesca ^a   Squillacioti, Caterina ^a   Restucci, Brunella ^a   Mazzotta, Manuela ^b   Muzio, Lorenzo L ^c   Maiolino, Paola ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b REFERRAL CANCER CENTER OF BASILICATA   (Italy)

^c UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Apocrine glands; Canine; Metallothionein

Indexed keywords

METALLOTHIONEIN;

ANIMAL TISSUE; APOCRINE GLAND TUMOR; ARTICLE; CANCER GRADING; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DOG DISEASE; IMMUNOHISTOCHEMISTRY; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SWEAT GLAND TUMOR; WESTERN BLOTTING;

ANIMALS; APOCRINE GLANDS; BLOTTING, WESTERN; DOGS; METALLOTHIONEIN; SKIN NEOPLASMS;

EID: 84858757230     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Kägi JH: Overview of metallothionein. Methods Enzymol 205: 613-626, 1991.
2. Kojima S, Shimada A, Kodan A, Kobayashi K, Morita T, Yamano Y and Umemura T: Molecular cloning and expression of the canine metallothionein-III gene. Can J Vet Res 62(2): 148-151, 1998. (Pubitemid 128528041)
3. Shimada A, Yanagida M and Umemura T: An immunohistochemical study on the tissue-specific localization of metallothionein in dogs. J Comp Pathol 116(1): 1-11, 1997. (Pubitemid 27110520)
4. Palmiter RD, Findley SD, Whitmore TE and Durnam DM: MT-III, a brain-specific member of the metallothionein gene family. Proc Natl Acad Sci USA 89(14): 6333-6337, 1992.
5. Quaife C J, Glenda CE, Froelick J, Kelly EJ, Zambrowicz BP and Palmiter RD: Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry 33: 7250-7259, 1994. (Pubitemid 24208763)
6. Davis SR and Cousins RJ: Metallothionein expression in animals: a physiological perspective on function. Nutr 130(5): 1085-1088, 2000. (Pubitemid 30233251)
7. Kusakabe T, Nakajima K, Suzuki K, Nakazato K, Takada H, Satoh T, Oikawa M, Kobayashi K, Koyama H, Arakawa K and Nagamine T: The changes of heavy metal and metallothionein distribution in testis induced by cadmium exposure. Biometals 21(1): 71-81, 2008. (Pubitemid 351170143)
8. Hamer DH: Metallothionein. Annual Review of Biochemistry 55: 913-951, 1986.
9. Kägi JH, Kojima Y, Kissling MM and Lerch K: Metallothionein: an exceptional metal thiolate protein. Ciba Found Symp 72: 223-237, 1979.
10. Webb M and Cain K: Functions of metallothionein. Biochem Pharmacol 31(2): 137-142, 1982. (Pubitemid 12207509)
11. Jasani B and Schmid KW: Significance of metallothionein overexpression in human tumours. Histopathology 31(3): 211-214, 1997. (Pubitemid 27397912)
12. Goncharova EI and Rossman TG: A role for metallothionein in spontaneous mutagenesis. Cancer Res 54: 5318-5323, 1994.
13. Kondo Y, Woo ES, Michaska AE, Choo KHA and Lazo JS: Metallothionein null-cells have increased sensitivity to anticancer drugs. Cancer Res 55: 2021-2023, 1995.
14. Jasani B, Edwards M, Vujanic G, Navabi H, Variend R, Tanner S and Schmid KW: Infrequent overexpression of metallothionein (MT) in pediatric tumours and its possible significance. J Pathol 181: A38-A38, 1997.
15. Cherian MG, Jayasurya A and Bay BH: Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat Res 533(1-2): 201-209, 2003. (Pubitemid 37487869)
16. Cherian MG: The significance of the nuclear and cytoplasmic localization of metallothionein in human liver and tumor cells. Environ. Health Perspect 102(3): 131-135, 1994.
17. Goulding H, Jasani B, Pereira H, Reid A, Galea M, Bell JA, Elston CW, Robertson JF, Blarney RW and Nicholson RA: Metallothionein expression in human breast cancer. Br J Cancer 72(4): 968-972, 1995.
18. Alves SM, Cardoso SV, Bernardes VdF, Machado VC, Alves Mesquita R, Vieira do Carmo MA and Ferreira Aguiar MC: Metallothionein immunostaining in adenoid cystic carcinomas of the salivary glands. Oral Oncology 43(3): 252-256, 2007.
19. Theocharis S, Karkantaris C, Philipides, T, Agapitos E, Gika A, Margeli A, Kittas C and Koutselinis A: Expression of metallothionein in lung carcinoma: correlation with histological type and grade. Histopathology 40: 143-151, 2002. (Pubitemid 34122116)
20. Tan Y, Sinniah R, Bay BH and Singh G: Metallothionein expression and nuclear size in benign, borderline, and malignant serous ovarian tumours. J Pathol 189(1): 60-65, 2009.
21. Dincer Z, Jasani B, Haywood S, Mullins JE and Fuentealba IC: Metallothionein Expression in Canine and Feline Mammary and Melanotic Tumours. J Comp Pathol 125(2-3): 130-136, 2001. (Pubitemid 33026327)
22. Erginsoy SD, Sozmen M, Caldin M and Furlanello T: Metallothionein expression in benign and malignant canine mammary gland tumours. Res Vet Sc 81(1): 46-50, 2006. (Pubitemid 43323776)
23. Cardoso SV, Caliari MV, de Aguiar MC and Cassali GD: Immunohistochemical staining of metallothionein in canine mammary tumors: better survival with higher expression. Oncol Rep 12(6): 1317-1321, 2004.
24. Fuentealba IC and Mullins JE: Immunohistochemical demonstration of metallothionein in benign and malignant canine mammary tumours. Histol Histopathol 14(1): 51-61, 1999. (Pubitemid 29049353)
25. Gross TL, Ihrke PJ and Walder EJ: Epithelial tumors. In: Veterinary Dermatopathology. A Macroscopic and Microscopic Evaluation of Canine and Feline Skin Disease. (Mosby Year Book (ed). St. Louis, pp. 392-395, 1992.
26. Goldschmidt MH, Dunstan RW, Stannard AA, von Tscharner C, Walder EJ and Yager JA: Apocrine and modified apocrine gland tumors: In: Histological Classification of Epithelial and Melanocytic Tumors of the Skin of Domestic Animals, (Yvonne Schulman F (ed.). Armed Force Institute of Pathology. Washington, DC, pp. 28-30, 1998.
27. Kalaher KM, Anderson WI and Scott DW: Neoplasms of the apocrine sweat glands in 44 dogs and 10 cats. Vet Rec 127(16): 400-403, 1990.
28. Simko E, Wilcock BP and Yager JA: A retrospective study of 44 canine apocrine sweat gland adenocarcinomas. Can Vet J 44(1): 38-42, 2003. (Pubitemid 36267474)
29. Meuten Donald J: Tumors of the skin and soft tissues. In: Tumors in Domestic Animals. Meuten Donald J (ed.). Ames, Iowa, pp. 70-73, 2002.
30. Misdorp W: Histological classification and further characterization of tumours in domestic animals. Adv Vet Sci Comp Med 20: 191-221, 1976.
31. Bier B, Douglas-Jones A, Tötsch M, Dockhorn-Dworniczak B, Böcker W, Jasani B and Schmid KW: Immunohistochemical demonstration of metallothionein in normal human breast tissue and benign and malignant breast lesions. Breast Cancer Res Treat 30(3): 213-221, 1994. (Pubitemid 24262116)
32. Chun JH, Kim HK, Kim IH, Kim JH, Chang HJ, Choi IJ, Lim HS, Kim IJ, Kang HC, Park JH, Bae JM and Park JG: Increased expression of metallothionein is associated with irinotecan resistance in gastric cancer. Cancer Res 64(14): 4703-4706, 2004. (Pubitemid 38924509)
33. Pattanaik A, Shaw CF 3rd, Petering DH, Garvey J and Kraker AJ: Basal metallothionein in tumors: widespread presence of apoprotein. Inorg Biochem 54(2): 91-105, 1994. (Pubitemid 24218130)
34. Nartey N, Cherian MG and Banerjee D: Immunohistochemical localization of metallothionein in human thyroid tumors. Am J Pathol 129(1): 177-182, 1987. (Pubitemid 17157782)
35. McGee HM, Woods GM, Bennett B and Chung RS: The two faces of metallothionein in carcinogenesis: photoprotection against UVR-induced cancer and promotion of tumour survival. Photochem Photobiol Sci 9(4): 586-596, 2010.
36. Zeng J, Heuchel R, Schaffner W and Kägi JH: Thionein (apometallothionein) can modulate DNA binding and transcription activation by zinc finger containing factor Sp1. FEBS Lett 279(2): 310-312, 1991.
37. Fan LZ and Cherian MG: Potential role of p53 on metallothionein induction in human epithelial breast cancer cells. Br J Cancer 87(9): 1019-1026, 2002. (Pubitemid 35305656)
38. Ostrakhovitch E, Per-Erik O, Jianga S and Cherian MG: Interaction of metallothionein with tumor suppressor p53 protein. FEBS Lett 580(5): 1235-1236, 2006.
39. Cherian MG, Howell SB, Imura N, Klaassen CD, Koropatnick J, Lazo JS and Waalkes MP: Role of metallothionein in carcinogenesis. Toxicol Appl Pharmacol 126(1): 1-5, 1994. (Pubitemid 24168861)
40. Cardoso SV, Barbosa HM, Candellori IM, Loyola AM, Aguiar MC: Prognostic impact of metallothionein on oral squamous cell carcinoma. Virchow's Arch 441(2): 174-178, 2002. (Pubitemid 34983985)
41. Kondo Y, Kuo SM, Watkins SC and Lazo JS: Metallothionein localization and cisplatin resistance in human hormone-independent prostatic tumor cell lines. Cancer Res 55(3): 474-477, 1995.
42. Lazo JS and Pitt BR: Metallothioneins and cell death by anticancer drugs. Annu Rev Pharmacol Toxicol 35: 635-653, 1995.
43. Abdel-Mageed A and Agrawal KC: Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells. Cancer Gene Ther 4(3): 199-207, 1997. (Pubitemid 127667116)
44. Oyama T, Take H, Hikino T, Iino Y and Nakajima T: Immunohistochemical expression of metallothionein in invasive breast cancer in relation to proliferative activity, histology and prognosis. Oncology 53(2): 11-17, 1996.